Retrospective analysis of sociodemographic characteristics of inpatients at Kayseri Research and Training Hospital AMATEM Clinic Objective: The purpose of this study is to retrospectively determine the sociodemographic characteristics of inpatients with the diagnoses of alcohol and substance use disorder in AMATEM (Research, Treatment and Training Center for Alcohol and Substance Dependence) clinic of Kayseri Training and Research Hospital. Methods: Medical records of 1222 patients who were hospitalized at AMATEM clinic of Kayseri Training and Research Hospital between the years 2007-2015 were analyzed retrospectively and the obtained data were recorded on data sheets prepared by us. Statistical evaluation of the data was recorded in a database prepared by SPSS 23 software. Chi-square test was used for descriptive analyzes. The confidence level was taken as 95% and the statistical significance limit was accepted as p<0.05 for all analyses. Results: A total of 1222 patients were included in the study. Of the all patients, 94.8% were male, 5.2% were female, mean age was 33.6±10.83 years. The mean age of alcohol users was 39.8±8.7; the mean age of substance users was 27.5±12.68. The mean age of the patients suffering from alcohol dependence was significantly higher than the mean age of applicants with other addictions. Patients who were mostly single (49.6%) were living with parents or family (90.4%). The rate of those who were married among the alcohol dependents was higher than the ones in the other substance dependents group. The most common reason for admission was alcohol dependence (37.2%), while the second most common was cannabis dependence. The majority of patients were hospitalized 1-15 days (67.7%) and these patients were often discharged from the hospital upon their requests (59.8%). The rate of the patients hospitalized for the first time at the clinic was 59% and this was higher than the recurrent hospitalizations. A huge majority of inpatients were smokers (91.7%). Conclusion: This is the first study to investigate the socio-demographic and clinical characteristics of patients who were hospitalized in Kayseri Training and Research Hospital AMATEM Clinic. We think that our study will contribute to the comparative evaluation of the clinical and socio-demographic characteristics of the individuals who applied to other AMATEMs in our country. In this way, it will be useful for determining the changes that may be caused by regional differences in alcohol and substance use disorder and determining the common features that can be generalized independent of such local features.
Objective: The aim of this study was to examine the relationship between the level of attention deficit hyperactivity disorder (ADHD) symptoms and the attitudes of parents of children diagnosed with ADHD.Methods: According to the Diagnostic and Numerical Manual of Mental Disorders-IV diagnostic criteria, 66 children with an age range of 6-13 were diagnosed with ADHD and their parents who brought them to the interview. A total of 94 parents were included in the study, including both the mother and father of some children diagnosed with ADHD, the mother of some, and the father of some. Parents of the children were evaluated with the "Wender-Utah Rating Scale (WURS)", "Parenting Styles and Dimensions Scale (PSDS-SF)".Results: According to the results of our study; it was found that the permissive subscale scores of PSDS-SF were significantly higher in parents whose WURS scores were above the cut-off value compared to those whose WURS scores were below the cut-off value, and there was no significant difference between the two groups in terms of competent and authoritarian subscale scores of PSDS-SF. It was found that there was no significant association between parents' age and educational levels and their parent's attitudes. In addition, comparisons of parents in terms of ADHD symptom level and parental attitudes did not show significant differences between parents in terms of both variables. Conclusion:The results of our study showed that permissive attitudes were significantly higher in parents with high levels of ADHD symptoms. In a clinical approach to children diagnosed with ADHD, it is believed that evaluating the symptoms and attitudes of parents with ADHD and psychoeducation of parents about adult ADHD are important for treatment.
Melatonin is an indoleamine often used in children and adolescents. Melatonin is considered to be an effective clinical management for dyssomnias, sleep disorders present in children with attention-deficit hyperactivity, autism spectrum disorders, developmental delays. Quickacting capsules, controlled-release (CR) capsules, sublingual tablets and liquid forms are available. Melatonin is generally very well-tolerated in children and adolescents. The pharmacology, therapeutic applications, and side effects of melatonin are discussed. Although stimulants have been used most frequently in ADHD treatment their long term effects did not investigate well. Methylphenidate which is the most frequently prescribed stimulant's long term side effects on growth-development, cardiovascular, psychiatric and neurological systems are very important 2 . Stimulant diversion or misuse in long term has growing up in recent years and lead important consequences on community health 3 . Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) consortium was established in 2012 and experts on ADHD, drug safety, neuropsychopharmacology and cardiology developed a programme which investigates the long term possible side effects of stimulants 2 . In this presentation, long term side effects of stimulants (methylphenidate) will be reviewed through the perspective of ADDUCE work group study results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.